Updated Jul 16, 2026
St Leger Tina Amber is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $32K.

Tina Amber St Leger is an executive associated with Immunocore Holdings plc, a biotechnology company focused on developing T cell receptor therapies for cancer and other diseases. She has been involved in various roles within the company, contributing to its growth and strategic direction.
| Role | Insider |
|---|---|
| Notability | 60/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-19 | IMCR | Immunocore Holdings plc | S — Open-market sale | 1.0K | $32.35 | $32K |
| 2026-02-19 | IMCR | Immunocore Holdings plc | M — Option exercise | 2.1K | $0.00 |
Tina Amber St Leger is an executive associated with Immunocore Holdings plc, a biotechnology company focused on developing T cell receptor therapies for cancer and other diseases. She has been involved in various roles within the company, contributing to its growth and strategic direction.…
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($32K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live St Leger Tina Amber profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.